Last reviewed · How we verify
Progestin Only Pills
At a glance
| Generic name | Progestin Only Pills |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effect of Different Sex Hormone Profiles for the Response to Physical Training (NA)
- Ovulation Incidence in Oral Contraceptive Users (PHASE3)
- Evaluation of Anterior Tibial Knee Translation in Healthy Women With and Without Hormone Therapy (NA)
- Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant (PHASE4)
- Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens (PHASE2, PHASE3)
- Progestin-Only Pill Use and Breastfeeding Study (PHASE4)
- Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
- Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Progestin Only Pills CI brief — competitive landscape report
- Progestin Only Pills updates RSS · CI watch RSS
- Bayer portfolio CI